Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes.
about
Quantitative proteomics to study carbapenem resistance in Acinetobacter baumanniiIdentification of a general O-linked protein glycosylation system in Acinetobacter baumannii and its role in virulence and biofilm formationColonization of long term care facility patients with MDR-Gram-negatives during an Acinetobacter baumannii outbreak.Comparison of the virulence potential of Acinetobacter strains from clinical and environmental sources.Epidemiology and clonality of carbapenem-resistant Acinetobacter baumannii from an intensive care unit in Palermo, ItalyConceptual model for reducing infections and antimicrobial resistance in skilled nursing facilities: focusing on residents with indwelling devicesPotential of bacteriophage ΦAB2 as an environmental biocontrol agent for the control of multidrug-resistant Acinetobacter baumannii.Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance studyPhenotypic and molecular characterization of Acinetobacter clinical isolates obtained from inmates of California correctional facilitiesCharacterising the Transmission Dynamics of Acinetobacter baumannii in Intensive Care Units Using Hidden Markov ModelsPoly-N-acetyl-β-(1-6)-glucosamine is a target for protective immunity against Acinetobacter baumannii infections."Silent" dissemination of Klebsiella pneumoniae isolates bearing K. pneumoniae carbapenemase in a long-term care facility for children and young adults in Northeast Ohio.Epidemiologic and clinical impact of Acinetobacter baumannii colonization and infection: a reappraisal.In vivo-validated essential genes identified in Acinetobacter baumannii by using human ascites overlap poorly with essential genes detected on laboratory media.Prevalence of and risk factors for multidrug-resistant Acinetobacter baumannii colonization among high-risk nursing home residents.Bacterial microbiota of Kazakhstan cheese revealed by single molecule real time (SMRT) sequencing and its comparison with Belgian, Kalmykian and Italian artisanal cheesesMultidrug-Resistant Gram-Negative Bacteria: Inter- and Intradissemination Among Nursing Homes of Residents With Advanced Dementia.Rapid killing of Acinetobacter baumannii by polymyxins is mediated by a hydroxyl radical death pathwayUtility of Whole-Genome Sequencing in Characterizing Acinetobacter Epidemiology and Analyzing Hospital OutbreaksThe Response Regulator BfmR Is a Potential Drug Target for Acinetobacter baumannii.Assessing the burden of Acinetobacter baumannii in Maryland: a statewide cross-sectional period prevalence survey.Discriminative value of inflammatory biomarkers for suspected sepsis.New insights into dissemination and variation of the health care-associated pathogen Acinetobacter baumannii from genomic analysis.In Vitro antibacterial efficacy of 21 Indian timber-yielding plants against multidrug-resistant bacteria causing urinary tract infection.Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned.Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance.Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models.The role of antimicrobial stewardship in curbing carbapenem resistance.The complex epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae.Global Dynamic Proteome Study of a Pellicle-forming Acinetobacter baumannii Strain.Modeling Acinetobacter baumannii wound infections: The critical role of iron.Escherichia coli Overexpressing a Baeyer-Villiger Monooxygenase from Acinetobacter radioresistens Becomes Resistant to Imipenem.The Threat and Response to Infectious Diseases (Revised).Detection of viable antibiotic-resistant/sensitive Acinetobacter baumannii in indoor air by propidium monoazide quantitative polymerase chain reaction.Longitudinal epidemiology of multidrug-resistant (MDR) Acinetobacter species in a tertiary care hospital.Expression, purification, crystallization and preliminary crystallographic analysis of the phosphoglycerate kinase from Acinetobacter baumannii.Healthcare-associated pneumonia: a never-ending story.Prevalence of multidrug-resistant organisms and risk factors for carriage in long-term care facilities: a nested case-control study.Multidrug-resistant Acinetobacter baumannii infection, colonization, and transmission related to a long-term care facility providing subacute care.Epidemiology of bloodstream infections caused by Acinetobacter baumannii and impact of drug resistance to both carbapenems and ampicillin-sulbactam on clinical outcomes.
P2860
Q26995246-B1CDDF23-C715-4F8C-BECB-E8A3862A213FQ28484155-CE7A7C49-EA7F-427D-B015-0A65483CF43EQ33696742-0C2A6CC3-E107-4344-B60C-14EF2664C0C9Q34288902-63BDF0CE-847A-4DBD-8C9A-C760FB6CA4A4Q34346675-042085D8-C7EF-4EEA-B7CF-02336B5D9757Q34608962-A5E2B427-4A8F-44C2-A249-92495DCD8D27Q34802631-7F6B0444-D704-483B-AEF2-CDC9B8FC8526Q35066558-133260EA-A219-421F-80A1-3E6E57B47F40Q35066715-26D994BE-7FD9-4272-8127-2A0217913B8FQ35679653-4D26ED50-7D60-461B-9966-C142B540B7CAQ35689459-7CA402C7-B5D2-44AA-B6E4-C66CA22F618AQ36115511-0A0AA692-9FBB-445F-A414-2127F4171F16Q36150941-2ECBCE01-F9E0-42C5-A8AD-5FC263CD4916Q36192633-3430A54C-4CE9-4BDF-A2E5-52DE70E14BA2Q36225143-5FDF3EB9-00ED-4F33-8FF8-837A91A9B801Q36244497-712842D7-3C9A-4611-9A20-48D83662D993Q36361814-C04CDE71-9940-4B05-A3D6-09E1A578F0FAQ36364121-103623D7-ACA7-423E-8AC4-E46CE8EE1C5FQ36620884-3C197E84-CB5C-40B0-BF80-90765C411C3CQ36956080-AFC7CC6C-5B92-4D2F-ABC7-DB7AB066A2A6Q37037692-919B37D9-C94A-4077-BA2F-EB47AD1562C5Q37086586-7B33A1A2-832D-4767-A837-9F994ED6D9A2Q37519869-7988F6DB-B9CF-486A-8CE4-500366A9AEA8Q37579696-4E57CA65-1ACE-45D8-B6D3-2A5B83905417Q37648626-646134A4-BCAE-468F-8938-9A641164FD63Q37869910-8549E997-51EA-406D-98F2-32F792A5344BQ38008459-8C9B4277-7C81-496F-A012-CC9F93DDAB5EQ38125493-1B41DD63-611C-41D1-90EA-BB5C1AE370D3Q38497797-33B56651-C703-4268-AC5F-DEC9E4859FD8Q39230013-30C1A63D-7605-4D14-81E9-2A338BE63EC4Q40392875-0752EE3F-7E41-4951-BC6D-BB1B64F6CC0BQ40439693-1E53E631-E390-4864-9B80-07EECEE47072Q40592880-27ACE439-1BD9-4197-A8B6-7661ED951984Q41715893-9929CEA7-E082-47A5-8676-176FCADFD346Q41811253-8F501502-7E6F-42B8-A847-0A4D819B0FA9Q41877948-57E18013-0B2A-4F16-B85C-D390C6BB88F3Q42060365-CCC15CB0-03E7-4759-B367-4FBF4CB3A97CQ42220295-BCABBFDF-9480-4437-B3FF-12FD0F85B26DQ42225315-52C010FA-FB01-4221-AF73-EE643BCD82BEQ42245284-855A96A8-2159-46F1-BC6E-38C98B7265E2
P2860
Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Multidrug-resistant Acinetobac ...... y hospitals and nursing homes.
@en
Multidrug-resistant Acinetobac ...... y hospitals and nursing homes.
@nl
type
label
Multidrug-resistant Acinetobac ...... y hospitals and nursing homes.
@en
Multidrug-resistant Acinetobac ...... y hospitals and nursing homes.
@nl
prefLabel
Multidrug-resistant Acinetobac ...... y hospitals and nursing homes.
@en
Multidrug-resistant Acinetobac ...... y hospitals and nursing homes.
@nl
P2093
P356
P1476
Multidrug-resistant Acinetobac ...... y hospitals and nursing homes.
@en
P2093
D M Sengstock
R Thyagarajan
P304
P356
10.1086/652759
P407
P50
P577
2010-06-01T00:00:00Z